Drug
Fosrenol
Fosrenol: highest development phase Phase 3, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fosrenol (Lanthanum Carbonate) NCT00441545 | Phase 3 | Chronic Kidney Disease, Stage 5 |
Latest
No recent events.
Follow Fosrenol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.